Cagrilintide, also known as cagrilinitide or AM833, is a long-acting amylin analogue used in modern weight loss and metabolic health research. It is most commonly discussed alongside GLP-1 peptides because amylin and GLP-1 pathways can affect appetite and satiety through different mechanisms.
Most people looking at cagrilintide are interested in appetite control, body-weight management, satiety signaling, metabolic health, and combination protocols with semaglutide or other GLP-1 peptides.
Mechanistically, cagrilintide acts on amylin receptor pathways involved in satiety, gastric emptying, glucagon regulation, and food intake. That makes cagrilintide especially interesting as a complement to GLP-1-based weight loss research rather than just another GLP-1 peptide.
Each vial contains 10mg of lyophilized cagrilintide powder for reconstitution with bacteriostatic water.
Reconstitution: Reconstitute with bacteriostatic water. Add the water slowly down the inside wall of the vial and let the powder dissolve gently. Do not shake.
Storage: Store at -20 degrees C in lyophilized form. Refrigerate reconstituted solution at 2-8 degrees C and use within 30 days.
For Research Purposes Only. Not for human consumption. Not for veterinary use. Sold strictly for in vitro and laboratory research applications.
